Transdel Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically delivered medications. The Company's lead topical drug, Ketotransdel™, utilizes the Company's innovative proprietary Transdel™ cream formulation to facilitate the passage of ketoprofen, an NSAID, through the skin barrier to reach targeted underlying tissue where the drug exerts its prolonged localized anti-inflammatory and analgesic effect. The Company is also investigating other drug candidates and treatments for transdermal delivery using the patented Transdel™ platform technology for products in pain management and other therapeutics areas.

Monday, May 19, 2008 - Rodman & Renshaw 5th Annual Global Healthcare Conference